Kim P. Kamdar

Insider Reports History

Identity
Location
Princeton, NJ
SEC record
Reporting signature
/s/ Benjamin G. Jackson, Attorney-in-fact
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Kim P. Kamdar:

Form 4 holding Director

Singular Genomics Systems, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
$0
Report date
21 Feb 2025
Price
$8.84
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kim P. Kamdar

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .